Elsevier

Psychiatry Research

Volume 262, April 2018, Pages 357-358
Psychiatry Research

ABCB1 C3435T polymorphism is associated with tetrahydrocannabinol blood levels in heavy cannabis users

https://doi.org/10.1016/j.psychres.2017.09.006Get rights and content

Abstract

ABCB1 polymorphisms are known to modify drug pharmacokinetics but have yet to be studied for their role in generating and maintaining cannabis dependence. The objective of this study is to determine if ABCB1 C3435T (rs1045642) polymorphism may modulate Δ9-Tetrahydrocannabinol (THC) blood levels in a sample of heavy cannabis users. The study sample includes 39 Caucasian individuals, recruited in two French addictology centres, with isolated cannabis dependence and heavy use (defined as ≥ 7 joints per week). Each underwent clinical evaluation, cannabis blood metabolite dosage (THC, 11-OH-THC, and THC-COOH) and genotyping of ABCB1 C3435T polymorphism. In this population (males: 74.4%, average age 29.5 +/− 9), average cannabis use was 21 joints per week (median 12; range 7 – 80). T carriers (TT/CT) had significantly lower plasma THC levels (ng/ml) versus non T carriers (8 vs 15.70, significant), controlling for level of weekly use, 11-OH-THC and THC-COOH levels. Our results show that ABCB1 C3435T polymorphism may modulate serum THC levels in chronic heavy cannabis users. The exact mechanisms and roles that this may play in cannabis dependence genesis and evolution remain to be elucidated. These results should be controlled in a replication study using a larger population.

Section snippets

Conflict of interest

No competing interests are declared by any of the authors.

References (5)

There are more references available in the full text version of this article.

Cited by (11)

  • Genetic variation and acute responses to cannabis

    2023, Cannabis Use, Neurobiology, Psychology, and Treatment
  • Drugs of Abuse

    2018, Side Effects of Drugs Annual
    Citation Excerpt :

    However, the C variant allele is associated with higher intestinal PgP expression and thus, more rapid drug efflux. The authors hypothesize that decreased THC concentrations seen with chronic users carrying the T allele may be due to higher THC body stores that are slowly released back into circulation overtime, which suggests that T allele carriers may have milder cannabis withdrawal symptoms than non-T carriers [34c]. THC, the primary psychoactive ingredient in cannabis, produces its psychoactive effects by binding to cannabinoid 1 (CB1) receptors in CNS.

  • Cannabis Pharmacogenomics: A Path to Personalized Medicine

    2023, Current Issues in Molecular Biology
View all citing articles on Scopus
View full text